abcbourse.com

Johnson & Johnson: shares still falling after talc scandal


Actualité publiée le 17/12/18 16:23
(CercleFinance.com) - Johnson & Johnson shares extend their losses on Monday, as investors did not seem to be reassured by the US healthcare giant's stance after a scandal linked to talk hit the shares on Friday.

J&J shares are currently down 3.3%, while New York's broader Dow Jones index is down 1.1%.

The stock had slid over 10%, wiping out roughly 45 billion dollars in market-cap on Friday following news that the company was aware its baby powder contained traces of asbestos.

In a statement, the company said the Reuters article was 'one-sided, false, and inflammatory.'

'Johnson & Johnson's baby powder is safe and asbestos-free,' the group commented. 'Studies of more than 100,000 men and women show that talc does not cause cancer or asbestos-related disease,' it added.

J&J said that thousands of independent tests by regulators and the world's leading labs have showed that its baby powder has never contained asbestos.

Copyright © 2018 CercleFinance.com. Tous droits réservés.

Vous avez aimé cet article ? Partagez-le avec vos amis en cliquant sur les boutons ci-dessous :

Actualités relatives

21/08/25 Johnson & Johnson : ouverture d'une unité de production en Caroline du Nord
21/08/25 Johnson & Johnson ouvre un nouveau site de production aux États-Unis
29/07/25 J&J: sollicite la FDA pour élargir l'indication du Tremfya à l'arthrite
29/07/25 J&J: lance une solution IA pour la chirurgie du pied
23/07/25 J&J: feu vert de l'UE pour une indication élargie d'Imbruvica
23/07/25 J&J: l'UE approuve une nouvelle indication pour Darzalex dans le myélome